Skip to Main Content (Press Enter)

×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca

UNIFIND

|

UNIFIND

unisr.it

×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca

Pubblicazioni

EUROPEAN JOURNAL OF CANCER

Rivista

Codice:

E060604

ISSN:

0959-8049

Dati Generali

Dati Generali

Pubblicazioni (97)

Ordina Pubblicazioni:

ascendente
decrescente

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer

Articolo

A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma

Articolo

A randomized trial comparing sentinel lymph node biopsy vs. no axillary surgical staging patients with small breast cancer and a negative preoperative axillary assessment

Abstract

A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer

Articolo

A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

Articolo

Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial

Articolo

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

Articolo

Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study

Articolo

Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis

Articolo

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy

Articolo

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening

Articolo

Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis

Articolo

Breast cancer in pregnancy: recommendations of an international consensus meeting

Articolo

Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe

Articolo

Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis

Articolo

Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma

Articolo

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

Articolo

Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study

Articolo

Combined therapy for primary central nervous system lymphoma in immunocompetent patients

Articolo

Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy

Articolo

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

Articolo

Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)]

Articolo

Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours

Articolo

Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe

Articolo

Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours.

Articolo

Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients – Results from the prospective AXSANA registry trial

Articolo

Discovery of I-0436650, a potent and selective SHP2 allosteric inhibitor for the treatment of RAS driven solid tumors

Articolo

Down-regulation of SPARC/osteonectin/BM-40 expression in methylcholanthrene-induced fibrosarcomas and in Kirsten-MSV transformed fibroblasts

Articolo

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population

Articolo

Erratum to “Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life” [Eur J Cancer (2016) 69 (110–118)] (S095980491632487X)(10.1016/j.ejca.2016.10.004)

Articolo

Erratum: Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe (European Journal of Cancer (2012) 48:2 (159-169))

Articolo

European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)

Articolo

Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure

Articolo

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group

Articolo

Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer

Articolo

Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer

Articolo

First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?

Articolo

Focal immune-related pancreatitis occurring after treatment with programmed cell death 1 inhibitors: a distinct form of autoimmune pancreatitis?

Articolo

Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab

Articolo

Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients

Articolo

High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy

Articolo

Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer

Articolo

How to Improve the Extent of Surgery With Better Neurological Function Preservation

Contributo in Atti di convegno

Human chorionic gonadotropin–positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)

Articolo

Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper

Articolo

Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors

Articolo

Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial

Articolo

Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections

Articolo

Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential

Articolo

Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.

Articolo

Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale

Articolo

Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care during COVID-19 outbreak in North-Eastern Italy. When the going gets tough, the tough gets going!

Poster

Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial

Articolo

Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!

Articolo

Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients

Articolo

One-stage versus two-stage implant-based breast reconstruction after breast surgery for cancer

Abstract

Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial

Articolo

Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response

Articolo

Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies

Articolo

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

Articolo

Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease

Articolo

Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era

Articolo

Predicting survival of men with recurrent prostate cancer after radical prostatectomy

Articolo

Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations

Articolo

Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer

Articolo

Primary central nervous system lymphoma - Biological aspects and controversies in management

Articolo

Primary non-Hodgkin's lymphoma of the bone (PLB): Management of 21 cases

Abstract

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Articolo

Prostate volume and adverse prostate cancer features: Fact not artifact

Articolo

Quality indicators in breast cancer care

Articolo

Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

Articolo

Response to letter entitled Re: Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients

Articolo

Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis

Articolo

Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009

Articolo

Safety of treatment with nivolumab after ipilimumab-related meningoradiculitis and bilateral optic neuropathy

Articolo

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial

Articolo

Sentinel Lymph Node (SLN) Biopsy in earlybreast cancer guided by indocuyanine green (ICG) fluorescence imaging method - preliminary experience and ongoing trial

Articolo

Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients

Articolo

Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial

Articolo

Short term outcome and quality of life in laparoscopic and open TME

Abstract

Significant improvement of response rate and survival with cisplatin, epirubicin, 5-fluorouracil and gemcitabine (PEF-G regimen) in metastatic pancreatic cancer

Abstract

Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail - a Novel Prognostic Parameter for Patients Selection

Abstract

Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group

Articolo

Symultaneous weekly carboplatin (CBDCA) and conventional radiotherapy (RT) for patients with unresectable head and neck cancer (HNC)

Articolo

Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies

Articolo

Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial

Articolo

The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy

Articolo

The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: A North American validation

Articolo

The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer

Articolo

The effect of radiotherapy on axillary recurrence after negative sentinel lymph node biopsy

Articolo

The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review

Articolo

The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials

Articolo

The prognostic role of high Ki-67 in early breast cancer patients who do not receive axillary dissection or axillary radiotherapy

Abstract

Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients

Articolo

Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy

Articolo

Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report

Articolo

[18F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial

Articolo

No Results Found

«
‹

{pageNumber}

›
»

{startItem} - {endItem} di {itemsNumber}

Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.0.0